R&D | pharmaphorum

R&D

Partner Content

Cell & Gene Therapy Summit 2023

Enabling market access, policy, and delivery 24th-25th April 2023, Brussels

News

Sanofi, Regeneron’s wager on Dupixent in COPD pays off

Approval in COPD could unlock a $3 billion market opportunity for the drug, say analysts.

News

89bio shows its NASH hand, boosting FGF21 concept

Positive phase 2b results on liver fibrosis follow similar data with a rival drug from Akero.

News

Novartis pulls plug on landmark UK cholesterol trial

ORION-17 study has been abandoned, with Novartis opting instead for a smaller global trial.

News

Astellas GLOWing as Claudin drug aces gastric cancer trial

Pair of positive phase 3 studies means company will file for approval of zolbetuximab soon.

News

89bio shows its NASH hand, boosting FGF21 concept

Positive phase 2b results on liver fibrosis follow similar data with a rival drug from Akero.

News

Novartis pulls plug on landmark UK cholesterol trial

ORION-17 study has been abandoned, with Novartis opting instead for a smaller global trial.

News

Astellas GLOWing as Claudin drug aces gastric cancer trial

Pair of positive phase 3 studies means company will file for approval of zolbetuximab soon.

Debates & Insights

Webinars

Sponsored

Synthetic control arms in clinical trials: Making it happen

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials.

Webinars

Sponsored

How synthetic control arms are changing clinical trials

Clinical trials are involved, expensive, and have been done largely the same way for decades but with today’s technology all that can change.

News

Sanofi, Regeneron’s wager on Dupixent in COPD pays off

Approval in COPD could unlock a $3 billion market opportunity for the drug, say analysts.

News

89bio shows its NASH hand, boosting FGF21 concept

Positive phase 2b results on liver fibrosis follow similar data with a rival drug from Akero.

Press Releases

Views & Analysis

Touring Chiesi's vision for the future at the new Biotech Ce...

Following an invite to fly into Parma, Italy to witness first-hand the press launch of the considerable structure – black-painted and as yet under construction, gigantic cranes and all – th

News

Vir awarded $1 billion multi-year BARDA influenza contract

The US Government’s Biomedical Advanced Research and Development Authority (BARDA) has made an

Views & Analysis

Patients

Challenges and opportunities with plasma-derived therapies

This newest pharmaphorum podcast welcomes Takeda's Dr Kristina Allikmets.

R&D

Open science: disrupting scientific community collaboration

The quiet rise of collaboration among pharma companies has never been more important.

R&D

Making a difference for traumatic brain injury patients

TBI is the leading cause of death and disability in young adults in the developed world.

Deep Dive

R&D

Highlights & Headlines from Deep Dive: R&D

pharmaphorum’s Deep Dive magazine is back to explore trends, challenges, & innovations in R&D.

R&D

Inside out – the coming of age of organ-on-a-chip technology

Perhaps the most beautiful thing about pharmacology, and the healthcare industry at large, is the continued pursuit of new ideas and innovations.

R&D

Research & Development 2023

So, what does 2023 have in store for pharma R&D?

R&D

Sponsored

Trials and tribulations of drug development

What does it take to establish new treatments for rare diseases?

R&D

Sponsored

An inside guide to unlocking clinical research in the UK

R&D

Sponsored

An inside guide to unlocking clinical research in the UK

Podcasts

Patients

Video

R&D

Event

R&D

Partner Content

Cell & Gene Therapy Summit 2023

Enabling market access, policy, and delivery 24th-25th April 2023, Brussels

Partner Content

R&D

Partner Content

Cell & Gene Therapy Summit 2023

Enabling market access, policy, and delivery 24th-25th April 2023, Brussels

R&D

Partner Content

The Challenge Of Finding KOLs For Innovative Therapies

You have a truly innovative medicine with a unique proposition in an area with a clear unmet need

Digital

Newel Health begins next phase of development of Soturi

Newel Health's Soturi, a DTx solution for Parkinson’s Disease, begins next phase.

Cell & Gene Therapy Summit 2023

Sanofi, Regeneron’s wager on Dupixent in COPD pays off

89bio shows its NASH hand, boosting FGF21 concept

Novartis pulls plug on landmark UK cholesterol trial

Astellas GLOWing as Claudin drug aces gastric cancer trial

89bio shows its NASH hand, boosting FGF21 concept

Novartis pulls plug on landmark UK cholesterol trial

Astellas GLOWing as Claudin drug aces gastric cancer trial

Synthetic control arms in clinical trials: Making it happen

How synthetic control arms are changing clinical trials

Sanofi, Regeneron’s wager on Dupixent in COPD pays off

89bio shows its NASH hand, boosting FGF21 concept

Touring Chiesi's vision for the future at the new Biotech Ce...

Vir awarded $1 billion multi-year BARDA influenza contract

Challenges and opportunities with plasma-derived therapies

Open science: disrupting scientific community collaboration

Making a difference for traumatic brain injury patients

Highlights & Headlines from Deep Dive: R&D

Inside out – the coming of age of organ-on-a-chip technology

Research & Development 2023

Trials and tribulations of drug development

An inside guide to unlocking clinical research in the UK

An inside guide to unlocking clinical research in the UK

Challenges and opportunities with plasma-derived therapies

Investing in healthcare futures: Elia Stupka and Paul Tunnah

Live from Frontiers Health 2022 - the pharmaphorum podcast

Highlights & Headlines from Deep Dive: R&D

JP Morgan 2023 – Joe Spinelli

JP Morgan 2023 – Lisa Yañez

Cell & Gene Therapy Summit 2023

Cell & Gene Therapy Summit 2023

The Challenge Of Finding KOLs For Innovative Therapies

Newel Health begins next phase of development of Soturi

Rezzayo antifungal okayed as Candida auris rings alarm bells

An inside guide to unlocking clinical research in the UK

Others Old
-About pharmaphorum
-Articles
--eyeforpharma Barcelona 2015
-Audio
-barelonalive 2016
-Cancer
-Diabetes
--Diabetes
-Disease Spotlight
--DMD Main
--LHON Main
-ESMO2016
-ESMO2016-related
-Event coverage
--ASCO-slider
--ASCO-pp
--ASCO-contributor
--ASCO 2018
-Featured content right column
-Featured Event
-Jobs
--pharmaphorum-live
-Medical Affairs Spotlight
--Medical Affairs Spotlight - partner
--Medical Affairs Spotlight - main
-Podcast
-Premium media
-Quintiles
--Quintiles-oncol-PC
--Quintiles - ContentIO
--Quintiles - Articles
--Quintiles - Oncol articles
-Roundtables
--AZ-roundtable-biographies-2017
--AZ-roundtable-interviews-2017
--AZ-roundtable-debate-2017
-Sales and Marketing
--News
--Insights
--Appointments
--Debates
--Debates & Insight
--Views & Analysis
--Partner Content
-Slider in events
-Slider in home page
-Slider in video
-Slider in views and analysis
-Slider in webinars
-Slider in whitepapers
-Spotlight
--Understanding HCPs
--Future of Generics
--Frontiers Health 2022
--Frontiers Health 2021
--Behavioural Science
--ASCO 2019 Live coverage
--AI in Pharma Marketing
--ASCO 2019 and the future of oncology
-Startups
--Views & Analysis
--News
-System
-Top pharmaceutical companies
--Bristol-Myers Squibb
--Teva
--Roche
--Pfizer
--Novo Nordisk
--Novartis
--Merck Inc
--GlaxoSmithKline
--Gilead
--AstraZeneca
--AbbVie
-Top pharmaceutical companies
--Merck Inc
-Top stories
-Transversal Categories
--Brexit
--Clinical
--Digital and Social Media
--US
---Articles
--UK & Europe
--Sales and Marketing
--Rare diseases
--R&D
--Pharma Market Access
--M&A
--Healthcare
-Veeva
-Veeva channel content articles
-Veeva channel content webinars
-Video
-Views and analysis
-Webinars in home page
-Whitepapers
Others
-Transversal Categories
--Clinical
--Sustainability
--Brexit
--Digital and Social Media
--Healthcare
--US
--UK & Europe
--Sales & Marketing
--Rare diseases
--R&D
--Pharma Market Access
--M&A
-Top stories
-About pharmaphorum
-Top pharmaceutical companies
--Gilead
--Merck Inc
--Teva
--Roche
--Pfizer
--Novo Nordisk
--Novartis
--GlaxoSmithKline
--Bristol-Myers Squibb
--AstraZeneca
--AbbVie
-test webinar
-System
-Startups
--News
--Views & Analysis
-Veeva channel content webinars
-Webinars in home page
--Live webinar
--Webinars On demand
-Veeva channel content articles
-Veeva
-Spotlight
-Event coverage
--ASCO-slider
--ASCO-pp
--ASCO-contributor
--ASCO 2018
-ESMO2016-related
-ESMO2016
-Featured Event
-Disease Spotlight
--LHON Main
--DMD Main
-Diabetes
--Diabetes
-Cancer
-barelonalive 2016
-Audio
-Articles
--eyeforpharma Barcelona 2015
-Slider in whitepapers
-Featured content right column
-Jobs
--pharmaphorum-live
-Roundtables
--AZ-roundtable-interviews-2017
--AZ-roundtable-biographies-2017
--AZ-roundtable-debate-2017
-Slider in webinars
-Slider in views and analysis
-Slider in video
-Slider in home page
-Slider in events
-Quintiles
--Quintiles-oncol-PC
--Quintiles - Oncol articles
--Quintiles - ContentIO
--Quintiles - Articles
-Premium media
-Medical Affairs Spotlight
--Medical Affairs Spotlight - partner
--Medical Affairs Spotlight - main
Home
-News
-Views & Analysis
-Deep Dive
-Webinars
--Live webinar
-Podcasts
-Videos
-White Papers
-Events
--JP Morgan
--LSX Investech
--Anthropy
--Reuters Pharma 2022
--World Cancer Series
--Hlth 2022
--PM Society Awards
--Patient Summit PC
--Frontiers Health 2022
--FHlive17
--ASCO 2018
-Digital Debates
-Podcasts & Videos
-Partner Content
--Events
--News
--Appointments
--Press releases
Digital
-Appointments
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Market Access
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Oncology
-Appointments
-Debates
-Insights
-News
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Patients
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
R&D
-Appointments
-Debates
-Debates & Insights
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Partner Content
-Debates & Insight
Sales & Marketing
-Debates
-Insights
-News
-Press Releases
-Views & Analysis
-Deep Dive
-Webinars
-Podcasts
-Video
-White Papers
-Event
-Debates & Insight
-Partner Content
Spotlight on
-AI in Pharma Marketing
-ASCO 2019 and the future of oncology
-ASCO 2019 Live coverage
-Behavioural Science
-Frontiers Health 2021
-Frontiers Health 2022
-Future of Generics
-Understanding HCPs
-The Future of Generics

Debates & Insights

News

Press Releases

Editor's Picks

Views & Analysis

Deep Dive

Webinars

Podcasts

Video

Event

Partner Content

Editor's Picks